A vaccine being produced by Pfizer may be 90 per cent effective in stopping the transmission of COVID-19 which has created a lot of excitement about getting the deadly virus under control and getting our lives back to normal. The Pfizer trial is one of four potential vaccines the Australian Government has signed an agreement to purchase if it is successful. Pfizer have announced they could produce 50 million doses by the end of this year and 1.3 billion by the end of next year.

In today’s Briefing topic we ask Dr Norman Swan about some of his concerns about the trial and what it means from here. We’re also joined by Dr Sheryl Recinos, a Californian doctor who was part of this very vaccine trial.

In today's headlines:

Pfizer vaccine reportedly being fast-tracked for Australian approval
Jobseeker supplement extended but reduced
Prime Minister won’t take disciplinary action after Four Corners report

Follow The Briefing

Instagram: @thebriefingpodcast
Facebook: TheBriefingNewsAU
Twitter: @TheBriefingAU

See omnystudio.com/listener for privacy information.

The COVID-19 vaccine: Your questions answered